Scientific Insights Center
To assist you in navigating the complex challenges of diagnosing autoimmune and allergy diseases, we have curated a selection of key published scientific communications. Our goal is to help you stay focused on what matters most—delivering answers that can transform patient care.
The Science Behind The MosaiQ® Platform & Assay Performance
Our assays run on the MosaiQ multiplex platform, designed to aid in the diagnosis of autoimmune diseases and allergy conditions.
By enabling a syndromic testing approach, simplifying workflows, and accelerating time to results, these assays empower clinicians to make more informed decisions.
Explore our autoimmune and allergy scientific communications below.
Autoimmune Connective Tissue Diseases
Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay Prototype for the Simultaneous Detection of Fifteen Autoantibodies Associated with Connective Tissue Diseases. Abstract 362 / Poster B-073; Annual Meeting of the Association for Diagnostics & Laboratory Medicine (ADLM); 2024;70(Suppl 1):i166. hvae106.435.
Analytical Evaluation of a Novel Fully Automated Multiplexed Microarray Immunoassay for the Simultaneous Detection of Eleven Autoantibodies Associated with Connective Tissue Diseases in a Spanish Reference Laboratory. Abstract 167 / Poster B-072; Annual Meeting of the Association for Diagnostics & Laboratory Medicine (ADLM); Clinical Chemistry. 2024;70(Suppl 1):i165-i166. hvae106.434.
Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay Prototype for the Simultaneous Detection of Fifteen Autoantibodies Associated with Connective Tissue Diseases. Poster P1283 Presented at the 26th International Congress of Clinical Chemistry and Laboratory Medicine (IFCC), Clin Chim Acta. 2024;558(Suppl 1): 118502.
Performance Characteristics of a Novel, Fully Automated Multiplexed Immunoassay Microarray Prototype for the Serological Detection of Eleven IgG Autoantibodies Commonly Found in Connective Tissue Diseases. Presented at the Annual Meeting of the American College of Rheumatologists. Abstract 0581. Arthritis & Rheumatology; 2023;75(S9):1148.
Performance Characteristics of a Novel, Fully Automated Planar Microarray Immunoassay for the Detection of Antibodies Against Centromere Protein B. Immunochemistry & Immunopathology. 2023;9(6):1-8.
Performance Characteristics of a New, Fully Automated Planar Microarray Immunoassay for the Detection of IgG Auto-antibodies Against Centromere Protein B (CENP-B). B-056 Presented at the Annual Meeting of the American Association of Clinical Chemistry (AACC). Clinical Chemistry. 2023;69(Suppl 1):hvad097.397.
Celiac Disease
Analytical Performance Characteristics of a Novel, Fully Automated Multiplexed Microarray Immunoassay Prototype for the Detection of Autoantibodies Associated with Celiac Disease. Presented at the 2024 Annual Scientific Meeting & Postgraduate Course of the American College of Gastroenterology (ACG). The American Journal of Gastroenterology. 2024; 119(10S):S1594.
Allergy
Performance Characteristics of a Novel, Fully Automated Immunoassay Microarray for the Qualitative Serological Detection of Specific IgE Directed Against Bet v 1. Abstract 1555 – P1.02.30 Presented at the 7th European Congress of Immunology. Eur J Immunol. 2024;54(Suppl 1): 579.
MosaiQ® Solution
A fully automated high throughput platform for multiplex testing of complex conditions for Autoimmune, Allergy, and beyond. The MosaiQ solution delivers fast actionable insights by combining advanced microarrays with an instrument engineered for ease-of-use and accuracy.
LumiQ™ Solution
Turnkey automated immunofluorescence solution, designed to provide workflow efficiency from patient sample to result.
End-to-end solution for autoimmune when combined with MosaiQ.
Autoimmune Assays
MosaiQ AiPlex® CD (Celiac Disease)
IVDR-CE Marked
MosaiQ AiPlex® CTDplus (Connective Tissue Diseases)
IVDR-CE Marked
Allergy Assays
AllergyPlex® COMBO
In Development
MosaiQ Demonstration
LumiQ Demonstration
Discover how our solutions can help optimize your lab’s workflow for improved efficiency.
© AliveDx Suisse SA, 2025. AliveDx, the AliveDx logo, MosaiQ AiPlex, AllergyPlex, LumiQ and MosaiQ are trademarks or registered trademarks of AliveDx group companies in various jurisdictions. Menus and capabilities are subject to change. Subject to regulatory authorization, not all methods may be available in all territories.
